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We report 5 years’ surveillance data from the Taiwan 
Centers for Disease Control on unexplained deaths and 
critical illnesses suspected of being caused by infection. A 
total of 130 cases were reported; the incidence rate was 
0.12 per 100,000 person-years; and infectious causes were 
identiﬁ  ed for 81 cases (62%).
I
n 2003, the outbreak of severe acute respiratory syn-
drome (SARS) demonstrated that the world has become 
a global village in which human risk for exposure to dif-
ferent kinds of biological hazards is increased through fre-
quent travel and commercial activities (1–5). Historically, 
emerging diseases occur abruptly in outbreaks of unknown 
cause. Although various efforts have been proposed and 
conducted to analyze secondary data periodically (6–9), 
they generally provide information for the less urgent deci-
sion making in health policy and may not be in time for 
infectious disease control. Thus, a task force is needed to 
provide timely and accurate diagnosis for early control of 
any potential epidemic infection, especially in a newly de-
veloped country like Taiwan, where the healthcare resourc-
es may not be evenly distributed and autopsy for diagnosis 
is not widely accepted culturally.
In 2000, the Taiwan Centers for Disease Control col-
laborated with academic institutions, medical examiners, 
local health authorities, and experts from different ﬁ  elds 
to establish a nationwide surveillance center for outbreak 
and unexplained death investigation due to unknown infec-
tious causes (COUNEX) (Figure). This effort was to build 
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Local COUNEX committee (at 4 TCDC branches): 
screening and information collection 
Investigation task force* 
supported by central and contract laboratories†: 
  investigations and data aggregation 
Review of medical records and all other relevant 
information (within 24 h) for a decision on whether 
an autopsy is indicated   
No  Yes 
Approved by patient’s family 
No 
Autopsy performed by designated 
pathologists at contract pathology 
laboratory at medical centers‡ 
Final review of etiologic evidence and decision by 
COUNEX committee at TCDC (composed of 
members from all 4 local branches)§ 
Yes 
Local health authorities, hospitals, or clinics 
report suspected infection-related cases through 
the “notifiable infectious disease surveillance 
system,” “syndromic surveillance system,” and 
toll-free notification hotline 
Figure. Flow of information and decision making for reported cases 
of unexplained death or critical illness. *If unexplained infectious 
causes were suspected, COUNEX mobilized an investigation 
team including experts, ﬁ   eld epidemiology training program 
members, public health workers from the local branch of Taiwan 
Centers for Disease Control (TCDC), and public health authorities 
to proceed with further ﬁ  eld investigation. TCDC was in charge of 
the investigation. †Cases were categorized into >1 of the following 
clinical syndromes: acute neurologic (encephalitis, meningitis), 
acute respiratory (pneumonia), acute hemorrhagic, acute diarrhea, 
acute jaundice (hepatitis), acute heart (myocarditis, pericarditis, 
endocarditis), and acute kidney-related. For every reported case, 
COUNEX investigators usually selected diagnostic tests relevant 
to a particular syndrome (www.cdc.gov.tw). Additional tests were 
prescribed if needed. The hospital laboratories were requested to 
save all remaining clinical specimens, including biopsy specimens, 
obtained from clinical management and send them to our reference 
laboratories, if indicated. ‡If an autopsy was performed, whenever 
possible tissue specimens were examined by pathologists of 
TCDC-designated medical centers and the Forensic Department of 
the Ministry of Justice to ensure the accuracy of the ﬁ  nal diagnosis. 
Specimens were also sent for microbiologic cultures and tests as 
well as toxicologic examination for trace toxic chemicals, if needed. 
§All laboratory results and clinical, epidemiologic, and pathologic 
data were sent to the expert committee to determine if the etiologic 
agent could fully or most likely explain the disease. Otherwise, 
cases were categorized as unexplained. In general, histopathogic 
examination was the major evidence for determining cause. If case-
patients could not be autopsied within 36 hours of death, laboratory 
results would be the most useful information for identiﬁ  cation of 
cause of death. Taiwan’s capacity for detecting and responding to uncom-
mon and unrecognized pathogens, which was conceptually 
the same as that of the study of Hajjeh et al. (10). We de-
ﬁ  ned the surveillance case-patient as a previously healthy 
resident who died or was admitted to a hospital with a life-
threatening illness possibly caused by infection of unidenti-
ﬁ  ed etiology. Usually the death occurred within 3 days of 
the patient’s admission. Patients were excluded if the cause 
of death was noninfectious. A life-threatening illness was 
deﬁ  ned as any illness requiring admission to an intensive 
care unit or reported as being critical. An infectious dis-
ease is generally suspected if the case-patient has >1 of the 
characteristics such as fever, leukocytosis, histopathologic 
evidence of an acute infectious process or more speciﬁ  c 
symptom patterns, or infection precipitating adult respira-
tory distress syndrome, renal failure, or sepsis.
A total of 130 cases were reported during 2000–2005, 
for an annual average rate of 0.12 cases per 100,000 per-
sons. The annual incidence rates varied by year and among 
4 branches of Taiwan Centers for Disease Control (Table). 
The highest rate was in the eastern branch, where sur-
veillance was conducted in a well-deﬁ  ned population of 
≈596,119 persons. Ninety-ﬁ  ve (73%) of the case-patients 
died. For 47 (49%) of those who died, an autopsy was per-
formed, a rate much higher than the national autopsy rate of 
<11% (12). The mean age of case-patients was 33.8 years. 
The incidence rates varied by age group; it was highest in 
those 85–89 years of age, followed by those <1–4 years, 
and then 65–69 years, with 0.48, 0.30, and 0.23 per 100,000 
person-years, respectively. Men had a higher incidence rate 
than women (0.16 vs. 0.10 per 100,000 person-years).
Approximately 10% of 130 case-patients and 16% of 
81 patients with cases of infection had a history of animal 
contact; 9% of 130 case-patients and 10% of infection case-
patients had a history of travel outside Taiwan within the 
previous 3 months. The most common initial syndromes 
were acute respiratory (59%), acute neurologic (22%), and 
acute diarrhea-related syndrome (13%). Initially, 8 patients 
had acute heart-related syndrome, and 11 had acute kidney-
related syndrome; both of these syndromes had a 100% 
case-fatality rate.
The online Appendix Table (www.cdc.gov/EID/
content/14/10/1653-appT.htm) lists all the infectious 
pathogens and noninfectious causes identiﬁ  ed among 95 
fatal cases. One third were related to bacterial infection and 
one fourth to viral infection; 22 remained unclassiﬁ  ed. The 
proportion of explained cases was lower among patients 
who survived (74%) than that among patients who died 
(77%). The proportion of explained cases was also higher 
for patients who underwent autopsy (83%) than for non-
autopsied patients (71%) but not statistically signiﬁ  cantly 
so. Explained cases were similar to unexplained cases in 
terms of patient age and interval between dates of disease 
onset and report (median 7.2 and 6.8 days, for explained 
and unexplained cases, respectively). Although the overall 
case-fatality rate was 73%, patients were more likely to die 
if they had multiple organ system involvement.
We have established the infrastructure needed to de-
tect critical and fatal cases of unknown causes; such a 
surveillance system is essential to identify early potential 
infectious threats in a period of globalization and increas-
ing travel between countries. The contributions of our sur-
veillance system are demonstrated by early detection and 
control of at least 3 outbreaks of serious viral diseases: han-
tavirus pulmonary syndrome, rabies, and SARS.
In 2001, a family cluster occurred in Huanlian city; 
dyspnea, cough, leukopenia, and pulmonary edema devel-
oped in both parents, who died. Their 16-year-old daugh-
ter was also ill, but she survived. COUNEX quickly inter-
vened, and hantavirus pulmonary syndrome was conﬁ  rmed 
by positive serologic test results, which led to an early con-
trol of local rodents and spread of the disease. 
Taiwan has been free of human and animal rabies 
since 1961. However in 2002, a 45-year-old woman from 
mainland People’s Republic of China was admitted to a 
hospital because of difﬁ  culty in swallowing, fear of wind 
(aerophobia), and numbness of the arms. Her condition was 
reported to the surveillance system as suspected rabies. Our 
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Table. Incidence rate of case-patients detected by surveillance and proportions of deaths, possible infectious causes, and autopsy, 
Taiwan, August 2000–March 2005 
TCDC branch* 
Category Total Northern Middle Southern Eastern
Incidence/100,000 person-years†  0.12 0.09 0.16 0.09 0.64
Proportion of deaths among all case-patients, %  73 75 64 79 83
Proportion of infectious causes identified, % 65 63 68 68 39
Viral agents among infection cases, %  42 56 30 37 57
Bacterial agents among infection cases, %  46 36 57 47 36
Rickettsia spp. among infection cases, %  4 4 3 0 14
Proportion of causes remaining unknown, %  23 25 16 29 25
Autopsy rate among patients who died, %  49 53 43 41 67
*TCDC, Taiwan Centers for Disease Control. 
†Denominators for the population under surveillance, obtained from the 2002 intercensus (11) and approximately the midpoint of this study period, 
included all people in the age groups under surveillance at the various sites and were used to calculate the incidence rate. Surveillance of Unexplained Deaths and Critical Illnesses
personnel quickly conﬁ  rmed the diagnosis by reverse tran-
scription–PCR and DNA sequence analysis of the samples 
from cerebrospinal ﬂ  uid, saliva, and trachea while the pa-
tient was still alive (13). The patient had been bitten by a 
domesticated dog in mainland China 2 months earlier. 
During the SARS outbreak in 2003, the surveillance 
system received reports of 6 cases; autopsies were per-
formed on 3 patients. As a result, the correlation between 
clinical course and pulmonary pathology at different stages 
of the disease was possible, and corroborative evidence for 
control measures was provided (14). 
Had the surveillance system for unexplained death 
and critical illness not functioned normally during these 3 
outbreaks, more people in Taiwan would have been ill and 
died from the diseases because of the high population den-
sity on this island. This system was particularly useful for 
infection control at remote regions with limited resources. 
Most physicians in the rural eastern part of the country have 
less access to consultation and referral to other specialties 
in medical centers and teaching hospitals. Thus, they rely 
more on this kind of surveillance system for early detection 
of potential infectious threats. This was especially impor-
tant for acute unexpected deaths, as was demonstrated by a 
higher incidence and autopsy rates in eastern Taiwan.
Throughout this project, we have increased the autopsy 
rate and established a population-based bank of specimens 
for future research. This collection could provide a better 
opportunity for corroboration or refutation of any previ-
ous diagnosis of infectious disease. This improved decision 
making in regard to control of infections was demonstrated 
in November 2003, when inﬂ  uenza virus (H5N1) was di-
agnosed in a patient who had a previous misdiagnosis of 
SARS (15).
Because emerging and reemerging infectious diseases 
may quickly travel between different countries, the system 
is becoming more crucial for early detection and control 
of potential health hazards. The system depends on close 
cooperation among different disciplines and staff from dif-
ferent agencies. Thus, education, empowerment, and good 
feedback incentives should be continually offered to keep 
this system sustainable.
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